Furthermore, we investigated the status of IKKβ/TSC1/mTOR signaling in specimens from HBV-associated human hepatomas, and analyzed the relationship between the status of IKKβ/TSC1/mTOR signaling and the prognosis of HCC patients. The gene discussed is MTOR; the disease is hepatocellular carcinoma.